FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 41 filers reported holding FORTE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 18.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $428 | +250.8% | 647 | +453.0% | 0.00% | – |
| Q2 2023 | $122 | -66.3% | 117 | -67.4% | 0.00% | – |
| Q1 2023 | $362 | +122.1% | 359 | +120.2% | 0.00% | – |
| Q4 2022 | $163 | – | 163 | -32.6% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 242 | -83.6% | 0.00% | – |
| Q2 2022 | $2,000 | -97.8% | 1,472 | -97.6% | 0.00% | – |
| Q1 2022 | $89,000 | -34.6% | 60,808 | -3.7% | 0.00% | – |
| Q4 2021 | $136,000 | +615.8% | 63,112 | +888.9% | 0.00% | – |
| Q3 2021 | $19,000 | -87.3% | 6,382 | +42.6% | 0.00% | – |
| Q2 2021 | $150,000 | +4.9% | 4,475 | +6.8% | 0.00% | – |
| Q1 2021 | $143,000 | – | 4,189 | +209350.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 2 | -99.9% | 0.00% | – |
| Q3 2020 | $187,000 | +9250.0% | 3,864 | +2023.1% | 0.00% | – |
| Q2 2020 | $2,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 66,390 | $2,232,000 | 1.54% |
| BVF INC/IL | 591,811 | $19,897,000 | 0.75% |
| Endurant Capital Management LP | 53,369 | $1,794,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,183,213 | $39,780,000 | 0.30% |
| Perceptive Advisors | 1,370,000 | $46,060,000 | 0.30% |
| ACT CAPITAL MANAGEMENT, LLC | 16,071 | $541,000 | 0.28% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 516,956 | $17,380,000 | 0.26% |
| Parkman Healthcare Partners LLC | 31,402 | $1,056,000 | 0.23% |
| Insight Advisors, LLC/ PA | 19,150 | $582,000 | 0.18% |
| MYDA Advisors LLC | 20,000 | $672,000 | 0.17% |